Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.
暂无分享,去创建一个
A. Tolcher | M. von Mehren | T. Mays | A. Patnaik | M. Mita | R. Cohen | N. Meropol | W. Halpern | N. Fox | K. Padavic | A. Corey | M. Hill | T. McCoy